Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TWH vs MMF in IgA Nephropathy
NCT02187900Phase 3Unknown
- Sponsor
- The Second Xiangya Hospital
- Start
- Jun 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tripterygium wilfordii polyglycosides in IgA nephropathy (IgAN), sponsored by The Second Xiangya Hospital. Status: unknown.
02
Drugs
tripterygium wilfordii polyglycosides
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT02187900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02187900.